Articles tagged with Analgesics
A study found no association between antiepileptic drugs and increased suicidal thoughts or actions in individuals with bipolar disorder. In fact, antiepileptic drug treatment may have a protective effect on suicidality, particularly among those not receiving other treatments.
A study led by St. Michael's Hospital found that deaths from opioid use in Ontario doubled between 1991 and 2004, with a five-fold increase in oxycodone-related deaths after OxyContin was introduced in 2000. Most opioid-related fatalities were accidental, and most people who died had visited a doctor recently.
Recent studies on anticoagulants suggest that aspirin and heparin may not be effective in preventing unexplained, recurrent miscarriages. In contrast, a new study shows that dabigatran etexilate is as safe and effective as warfarin for treating venous thromboembolism.
A UCLA study found that nearly 20% of stroke survivors were not taking antithrombotic medications, with non-Hispanic, older, and male patients more likely to be on these medications. The study suggests further research is needed to understand the reasons behind this disparity in medication adherence.
A randomized study found that percutaneous disc decompression provides sustained pain relief up to two years, while conservative therapy only offers short-term benefits. Disc decompression involves deflating the bulging disc and relieving nerve root pressure, allowing for improved mobility and quality of life.
Despite increased availability of prescription antiplatelet medications, the overall use of blood-thinning agents among stroke survivors has plateaued. Aspirin remains the predominant agent used for secondary stroke prevention, with no improvements in antithrombotic agent usage over a 7-year period.
A recent study found that low-dose aspirin may offer mild protection from AMD, reducing the risk by 18% in women who took the medication. However, statins did not show a significant impact on advanced AMD risk, with patients taking statins actually at a slightly higher risk of developing advanced disease.
University of Missouri researchers found that aspirin and Tylenol block enzymes that inhibit vaccines. This could lead to reduced antibody responses and decreased protection against infections.
A new self-assessment score has been developed to predict diabetes risk, showing promise as a simple and effective tool. Additionally, researchers are considering alternative bacteria, Fusobacterium necrophorum, for sore throat treatment due to its association with a rare but life-threatening complication, Lemierre syndrome. Furthermor...
Researchers at Newcastle University have scientifically proven the pain-relieving properties of Hyptis crenata, a traditional South American herb. The study showed that the herbal tea was as effective as Indometacin in relieving pain, with results comparable to synthetic aspirin-style drugs.
The initiative seeks to improve care for patients with sickle cell disease by establishing medical homes, providing comprehensive education, and encouraging specialization in the field. The project aims to reduce pain crises and hospitalizations through better prevention and treatment strategies.
A study by Stanford researchers identifies a molecular pathway that counters acetaminophen toxicity, which can lead to liver failure. The discovery highlights the potential of S-methylmethionine, a common herbal medicine supplement, in preventing liver damage caused by acetaminophen overdose.
Researchers found that yoga significantly reduced pain intensity and pain medication use in minority populations with chronic low back pain. The study, which included 12 weeks of hatha yoga classes, showed promising results for this often underrepresented population.
Research from the University of Rochester Medical Center found that using common pain killers like Advil and Tylenol at the time of flu injection can blunt the vaccine's effect. The study suggests that timing and dosage of pain relievers also play a role in reducing antibody production, which is necessary for immune protection.
A Henry Ford study found that pregabalin effectively reduced abdominal pain and improved sleep in women with adhesions, a common complication after abdominal or pelvic surgery. The study results suggest that pregabalin may be a viable treatment option for this painful condition.
Researchers found that young animals treated with commonly-prescribed mood, pain, and epilepsy drugs developed behavioral abnormalities in adulthood. The study suggests these drugs may predispose to psychiatric disorders later in life.
A Duke University researcher has discovered a receptor that receives messages from astrocytes, which can form excitatory synapses in the brain. The discovery may explain why people develop epilepsy or have neuropathic pain, and could lead to new therapies for these conditions.
Researchers found that aspirin and folic acid do not affect inflammation markers in patients with colorectal adenomas. However, low-dose aspirin was found to stabilize C-reactive protein levels, which may be affected by high folate intake.
The new centre will investigate mechanisms of pain in arthritis, develop new treatments, and target individual patients. Researchers will use a multi-disciplinary approach to gain a better understanding of how people experience pain.
A new study suggests that high aspirin dosing levels during the 1918-1919 influenza pandemic may have contributed to increased mortality. Autopsy reports from 1918 support this theory, as they show signs consistent with aspirin toxicity and viral causes of death.
A 12,500-person trial will assess daily low-dose aspirin on health in Australian and US seniors. The study aims to inform health guidelines for older adults, considering aspirin's potential benefits and side effects.
A new study by Queen's University researchers found that taking an anti-seizure drug and an antidepressant together is a more effective treatment for neuropathic pain than taking either individually. Patients experienced less pain and improved sleep when given both drugs, with significant improvements also seen in sleep interference.
A new study published in The Lancet found that combining gabapentin and nortriptyline is more effective than using either drug alone in reducing neuropathic pain. The treatment resulted in a significant reduction in pain scores, with patients experiencing relief from their symptoms.
Researchers found that acetaminophen intervention restored Akt activity in aged muscles, improving cell size and reducing death. The study's results suggest the pain reliever may be beneficial for treating age-related muscle dysfunction.
Researchers have developed a new vaginal device that delivers at least 10 times more medication to the uterus than existing oral medications, reducing side effects and potentially alleviating menstrual cramp pain. Phase II clinical trials will assess efficacy of the treatment in reducing pain.
Scientists have created an implantable device that utilizes magnetism to control the release of medication, allowing for precise and repeatable dosing. The device uses nanoparticles that heat up when exposed to a magnetic field, causing the drug to be released into the body.
A study published in the Journal of the American Geriatric Society found that people with persistent pain develop functional limitations at an earlier age than those without pain. The study revealed that individuals with pain have higher rates of mobility limitations and are more likely to experience disability.
University of Minnesota researchers identified genes producing THC, a psychoactive substance in marijuana, to create a drug-free Cannabis plant for hemp fiber and oil. The study also aims to develop new pain and nausea treatments.
A recent study published in Archives of Internal Medicine found that 29% of chronic angina patients experience angina chest pain at least once a week. Despite treatment options, many patients report limited enjoyment of life due to the symptom.
Researchers have discovered that applying capsaicin to specific skin locations can trigger signals in the nervous system, activating cellular pathways that protect the heart. This technique has shown promise in reducing cardiac cell death by up to 85%.
A head-to-head study confirms Instanyl's superiority over oral transmucosal fentanyl citrate (OTFC) in managing breakthrough cancer pain. Instanyl demonstrated significant pain relief at all time points, with patients preferring its ease of administration and faster onset of action.
The first results of the European survey show that breakthrough cancer pain episodes are frequent, short-lived, and intensely painful, with 96% described as moderate to severe. The study suggests that fast-acting pain relief routes like intranasal opioids could be more effective for BTCP, improving patient compliance.
Researchers found that the endothelin receptor plays a role in vaso-occlusive pain in sickle cell disease, with males more sensitized to pain. Females have more of the ETB receptor, which may explain better pain control and reduced sensitivity.
A study by Johns Hopkins Bloomberg School of Public Health found a significant increase in deaths from unintentional injuries, particularly among middle-aged white women and men. The death rate from falls increased by 38% for white men and 48% for white women 65 and older.
A surgically implanted capsule-sized pump has been developed to provide continuous pain relief for big cats, reducing the need for daily injections. The pump was successfully used on two leopards at a Tennessee sanctuary, demonstrating its effectiveness in delivering pain medication quickly and efficiently.
Recent studies suggest that aspirin may not provide significant benefits for primary prevention in all diabetics. However, the European Society of Cardiology recommends its use for individuals with a high cardiovascular risk profile. Aspirin has been shown to reduce the risk of myocardial infarctions and strokes in this population, par...
The Aspirin for Asymptomatic Atherosclerosis study found no statistically significant difference in primary endpoint events between those subjects allocated to aspirin or placebo. Vascular events and all-cause mortality were similar in both groups, but major bleeding occurred more frequently in the aspirin group.
A landmark international study found that high doses of clopidogrel significantly reduce stent thrombosis and heart attacks in patients undergoing angioplasty. The study showed a 30% reduction in stent thrombosis risk and a 22% lower risk of heart attack with the higher dose regimen.
The PLATO study demonstrated that ticagrelor reduced cardiovascular events by 16% compared to clopidogrel, with no increase in major bleeding. The efficacy of ticagrelor was observed across all major acute coronary syndromes patient types, with a consistent benefit seen in secondary endpoints.
A recent study by the Medical College of Wisconsin found that ibuprofen is as effective as acetaminophen with codeine in treating pain in children with arm fractures. The study showed that children treated with ibuprofen reported better functional outcomes and higher satisfaction rates than those receiving acetaminophen with codeine.
Regular aspirin use after diagnosis was associated with reduced risks of colorectal cancer-specific death and overall mortality. Participants who regularly used aspirin had a 29% lower risk of colorectal-specific mortality compared to nonusers.
Regular postdiagnosis aspirin use may reduce the risk of dying from colorectal cancer, with a nearly 30% lower risk seen in patients taking aspirin at least twice a week. The benefit is strongest among patients with COX-2-positive tumors.
A new computer system has been successfully tested at Heidelberg University Hospital to improve pain therapy for cancer patients. The system, AiDPainCare, was found to have little variance from international guidelines and reduced patient pain.
Researchers at the University of Michigan used brain imaging to study the effects of acupuncture on chronic pain. They found that traditional Chinese acupuncture increases binding availability of mu-opoid receptors in regions processing and dampening pain signals, leading to reduced pain levels.
A newly discovered compound from a soft coral may hold the key to developing effective treatments for neuropathic pain. The research suggests that inflammation in the nervous system is a major factor in this condition, and the compound has been shown to reduce pain-related activities in isolated microglia and experimental rats.
A study of heart disease patients reveals those with prior atherosclerosis are more likely to die in the hospital and receive less recommended therapy. Researchers found these patients were also more likely to have high blood pressure, diabetes, and earlier stroke and heart failure incidence.
A study of high school seniors found that most who took opioid medications without a prescription did so for reasons other than pain relief, including relaxation and getting high. Students who used the drugs only for pain relief were less likely to engage in heavy drinking or other substance use.
A new treatment method, Vesselplasty, has been shown to reduce pain and improve mobility in patients with vertebral compression fractures. The study, which included 29 patients, found significant improvements in pain scores and mobility, with no clinical complications reported.
Scientists have developed a more efficient method to produce a novel form of acetaminophen with reduced liver toxicity risk, offering a potential solution to the growing concern over the drug's effects.
The review examines the prevalence of prescription opioid addiction among patients and healthcare providers, citing risks and consequences. New approaches to minimize abuse and promote recovery are discussed, emphasizing the importance of awareness and treatment.
A phase III randomised controlled trial found that famotidine reduces the development of stomach ulcers by 90% and upper-intestinal ulcers by 95% compared to placebo. The study also showed fewer adverse events in the famotidine group.
A randomized trial of 200 patients found that midline and transverse incisions had the same healing process and post-surgical pain perception. However, wound infections were more frequent for transverse incisions, possibly due to circulatory problems.
Cancer patients often suffer from severe pain due to tumors releasing signal substances that make nerve cells sensitive; a new approach involves injecting proteins that block these effects. This discovery opens up new prospects in the fight against cancer pain and potentially reduces side effects for patients.
A study of 133 women with rheumatoid arthritis found that symptoms such as pain and depression significantly impacted sleep quality. Treating depression may also improve pain and medication adherence, according to researchers.
Aspirin use in primary prevention reduces non-fatal heart attacks by around 12%, mainly due to reduced risk of non-fatal heart attack. However, it also increases the risk of internal bleeding by around a third in healthy individuals.
According to a University of Pittsburgh study, African-American seniors are two times more likely than whites to prefer life-prolonging treatments when faced with a terminal illness. The majority of Medicare beneficiaries surveyed preferred not to die in a hospital or receive life-sustaining measures at the end of life.
Researchers developed a strategy to improve both depression and pain management by closely monitoring antidepressant therapy and providing pain self-management training. The study found that this approach led to substantial improvements in both conditions, with benefits lasting six months after treatment was completed.
A combined pharmacological and behavioral intervention improved depression and pain in patients with musculoskeletal pain and co-existing depression. The intervention significantly reduced symptoms of both conditions at 12 months.
A study published in PNAS identified TRPA1 as playing a key role in allergic asthma and demonstrated that HC-030031 effectively treated the condition in mice. This breakthrough research could represent a new avenue of treatment for asthma.
Scientists at Yale School of Medicine and Hydra Biosciences have discovered that a protein called TRPA1 may be a trigger of allergy-induced asthma in mice. Inhibiting this protein with a drug known for reducing pain could also reduce asthma symptoms, providing new hope for treatment.